{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:33:51Z","timestamp":1789403631389,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jcms.2021.05.007","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T23:48:19Z","timestamp":1623109699000},"page":"950-958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immune checkpoint analysis in lip cancer"],"prefix":"10.1016","volume":"49","author":[{"given":"M.","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Wermker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hallermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pannier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"H\u00f6lzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Modabber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcms.2021.05.007_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13325","article-title":"Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma","volume":"33","author":"Benzaquen","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"8","key":"10.1016\/j.jcms.2021.05.007_bib2","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/neuonc\/nou307","article-title":"Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma","volume":"17","author":"Berghoff","year":"2015","journal-title":"Neuro Oncol."},{"issue":"4","key":"10.1016\/j.jcms.2021.05.007_bib3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/DSS.0000000000001020","article-title":"Squamous cell carcinoma of the lip \u2014 a review of squamous cell carcinogenesis of the mucosal and cutaneous junction","volume":"43","author":"Bota","year":"2017","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.jcms.2021.05.007_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2018.0026","article-title":"NCCN guidelines insights: head and neck cancers, version 1.2018","volume":"16","author":"Colevas","year":"2018","journal-title":"J\u00a0Natl Compr Cancer Netw JNCCN"},{"issue":"14","key":"10.1016\/j.jcms.2021.05.007_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93652","article-title":"Multiparametric immune profiling in HPV-oral squamous cell cancer","volume":"2","author":"Feng","year":"2017","journal-title":"JCI Insight"},{"issue":"19","key":"10.1016\/j.jcms.2021.05.007_bib6","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jcms.2021.05.007_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2017.05.047","article-title":"Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck","volume":"77","author":"Garc\u00eda-Pedrero","year":"2017","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"issue":"21","key":"10.1016\/j.jcms.2021.05.007_bib8","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jcms.2021.05.007_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.humimm.2015.12.001","article-title":"Relevance of HLA-G, HLA-E and IL-10 expression in lip carcinogenesis","volume":"77","author":"Gon\u00e7alves","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jcms.2021.05.007_bib10","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/jamaoto.2016.3455","article-title":"Epidemiology of squamous cell carcinoma of the lip in the United States: a population-based cohort analysis","volume":"142","author":"Han","year":"2016","journal-title":"JAMA Otolaryngol. Neck Surg"},{"issue":"5","key":"10.1016\/j.jcms.2021.05.007_bib11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijom.2017.09.006","article-title":"Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma","volume":"47","author":"Hanna","year":"2018","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"12","key":"10.1016\/j.jcms.2021.05.007_bib12","first-page":"1407","article-title":"The PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer","volume":"18","author":"Henick","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"issue":"3","key":"10.1016\/j.jcms.2021.05.007_bib13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.21873\/anticanres.11465","article-title":"PD-L1 Expression confers better prognosis in locally advanced oral squamous cell carcinoma","volume":"37","author":"Kogashiwa","year":"2017","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.jcms.2021.05.007_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1634\/theoncologist.2016-0496","article-title":"FDA approval summary: pembrolizumab for the treatment of recurrent or metastatic head and neck squamous cell carcinoma with disease progression on or after platinum-containing chemotherapy","volume":"22","author":"Larkins","year":"2017","journal-title":"Oncol."},{"key":"10.1016\/j.jcms.2021.05.007_bib15","first-page":"400","article-title":"S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) \u2014 short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease","volume":"18","author":"Leiter","year":"2020","journal-title":"J\u00a0Dtsch Dermatol Ges J Ger Soc Dermatol JDDG"},{"issue":"11","key":"10.1016\/j.jcms.2021.05.007_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142656","article-title":"High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma","volume":"10","author":"Lin","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jcms.2021.05.007_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.archoralbio.2018.09.017","article-title":"Immune response and evasion mechanisms in lip carcinogenesis: an immunohistochemical study","volume":"98","author":"Lopes","year":"2019","journal-title":"Arch. Oral Biol."},{"issue":"7","key":"10.1016\/j.jcms.2021.05.007_bib18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ijom.2018.01.004","article-title":"Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma","volume":"47","author":"Maruse","year":"2018","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"22","key":"10.1016\/j.jcms.2021.05.007_bib19","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1158\/0008-5472.CAN-16-3453","article-title":"PD-1 expression in head and neck squamous cell carcinomas derives primarily from functionally anergic CD4+ TILs in the presence of PD-L1+ TAMs","volume":"77","author":"Mattox","year":"2017","journal-title":"Canc. Res."},{"issue":"4","key":"10.1016\/j.jcms.2021.05.007_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jcms.2021.05.007_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11864-019-0629-2","article-title":"Systemic immunotherapy for advanced cutaneous squamous cell carcinoma","volume":"20","author":"Ogata","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"issue":"1","key":"10.1016\/j.jcms.2021.05.007_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ijd.13446","article-title":"CD8+ and FoxP3+ T-cell infiltration in actinic cheilitis","volume":"56","author":"Rojas","year":"2017","journal-title":"Int. J. Dermatol."},{"issue":"5","key":"10.1016\/j.jcms.2021.05.007_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pathol.2017.04.004","article-title":"PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma","volume":"49","author":"Roper","year":"2017","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.jcms.2021.05.007_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00251-017-1015-5","article-title":"PD-1 and cancer: molecular mechanisms and polymorphisms","volume":"70","author":"Salmaninejad","year":"2018","journal-title":"Immunogenetics"},{"issue":"10","key":"10.1016\/j.jcms.2021.05.007_bib25","doi-asserted-by":"crossref","first-page":"16824","DOI":"10.1002\/jcp.28358","article-title":"PD-1\/PD-L1 pathway: basic biology and role in cancer immunotherapy","volume":"234","author":"Salmaninejad","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"issue":"6","key":"10.1016\/j.jcms.2021.05.007_bib26","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.pathol.2016.07.003","article-title":"Programmed cell death \u2014 ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype","volume":"48","author":"Satgunaseelan","year":"2016","journal-title":"Pathology"},{"issue":"8","key":"10.1016\/j.jcms.2021.05.007_bib27","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jcms.2014.06.022","article-title":"Cutaneous and oral squamous cell carcinoma \u2014 dual immunosuppression via recruitment of FOXP3+ regulatory T cells and endogenous tumour FOXP3 expression?","volume":"42","author":"Schipmann","year":"2014","journal-title":"J.\u00a0Cranio-Maxillo-Fac. Surg."},{"issue":"2","key":"10.1016\/j.jcms.2021.05.007_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12105-017-0857-3","article-title":"Beyond the percentages of PD-L1-positive tumor cells: induced versus constitutive PD-L1 expression in primary and metastatic head and neck squamous cell carcinoma","volume":"12","author":"Scognamiglio","year":"2018","journal-title":"Head Neck Pathol"},{"issue":"7","key":"10.1016\/j.jcms.2021.05.007_bib29","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.jcms.2021.05.007_bib30","first-page":"51","article-title":"The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012","volume":"67","author":"Shield","year":"2017","journal-title":"CA A Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.jcms.2021.05.007_bib31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cup.12728","article-title":"PD-L1 expression in cutaneous squamous cell carcinoma correlates with risk of metastasis","volume":"43","author":"Slater","year":"2016","journal-title":"J.\u00a0Cutan. Pathol."},{"issue":"3","key":"10.1016\/j.jcms.2021.05.007_bib32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12253-017-0270-y","article-title":"Immunohistochemical analysis of Foxp3+, CD4+, CD8+ cell infiltrates and PD-L1 in oral squamous cell carcinoma","volume":"24","author":"Stasikowska-Kanicka","year":"2018","journal-title":"Pathol. Oncol. Res."},{"issue":"11","key":"10.1016\/j.jcms.2021.05.007_bib33","doi-asserted-by":"crossref","first-page":"12024","DOI":"10.18632\/oncotarget.7593","article-title":"CD274\/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity","volume":"7","author":"Straub","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.jcms.2021.05.007_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.coi.2011.12.009","article-title":"Targeting the PD-1\/B7-H1(PD-L1) pathway to activate anti-tumor immunity","volume":"24","author":"Topalian","year":"2012","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"10.1016\/j.jcms.2021.05.007_bib35","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.joms.2016.11.006","article-title":"Is there evidence for the presence and relevance of the PD-1\/PD-L1 pathway in oral squamous cell carcinoma? Hints from an immunohistochemical study","volume":"75","author":"Troeltzsch","year":"2017","journal-title":"J.\u00a0Oral Maxillofac. Surg."},{"key":"10.1016\/j.jcms.2021.05.007_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2020.102419","article-title":"Predictors of occult lymph node metastases in lip cancer","volume":"41","author":"Walton","year":"2020","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.jcms.2021.05.007_bib37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jcms.2015.02.002","article-title":"Prediction model for lymph node metastasis and recommendations for elective neck dissection in lip cancer","volume":"43","author":"Wermker","year":"2015","journal-title":"J.\u00a0Cranio-Maxillo-Fac. Surg."},{"issue":"9","key":"10.1016\/j.jcms.2021.05.007_bib38","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00262-016-1867-9","article-title":"B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma","volume":"65","author":"Wu","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"issue":"7","key":"10.1016\/j.jcms.2021.05.007_bib39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.oraloncology.2014.04.003","article-title":"The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck","volume":"50","author":"Zandberg","year":"2014","journal-title":"Oral Oncol."}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518221001499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518221001499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:44:53Z","timestamp":1760885093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518221001499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1010518221001499"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2021.05.007","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune checkpoint analysis in lip cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2021.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}